Ownership

Nicole LaBrosse - SVP, CHIEF FINANCIAL OFFICER at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Svp, Chief Financial Officer
Stock Symbol: HALO on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Nicole LaBrosse - trading volume in the past year for Halozyme Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-35K	100%	$52.22	-$1.83M
Net	-35K	-100%		-$1.83M

Holdings reported by Nicole LaBrosse for Halozyme Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	31.9K	$1.84M	$57.75	Feb 23, 2025	Direct
Restricted Stock Units	20.1K	$1.16M	$57.75	Feb 23, 2025	Direct	Common Stock
Performance Stock Unit	6.94K	$391K	$56.41	Feb 12, 2025	Direct	Common Stock
Option to Purchase Common Stock	5K	$385K	$13.87	Jun 28, 2024	Direct	Common Stock
Option to Purchase Common Stock	22.6K	$314K	$13.87	Feb 20, 2025	Direct	Common Stock
Performance Stock Units	0	$0	$58.29	Feb 16, 2025	Direct	Common Stock

Transactions reported by Nicole LaBrosse for Halozyme Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.